BridgeMD
New treatment option for Subarachnoid Hemorrhage, Aneurysmal
Official title Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage
ClinicalTrials.gov ID: NCT06119061
What this study is testing
What is Telavancin Injection?
Telavancin Injection is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for subarachnoid hemorrhage, aneurysmal.
Also referred to as Vibativ.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The proposed study aims to evaluate the CNS penetration of telavancin in a critically ill population using cerebrospinal fluid (CSF) drawn from external ventricular drains (EVDs). Patients with EVDs were chosen as the target population because they frequently require prolonged admission to the intensive care unit and drainage of CSF in order to prevent hydrocephalus.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Adult aged 18-85 years
- Actively draining ventriculostomy
You likely can't join if
- history of hypersensitivity to telavancin or similar agents
- reduced renal function (estimated creatinine clearance \< 50/ml) at the time of consent
- severe anemia (hemoglobin \< 7gm/dl)
- vulnerable population (pregnant, prisoner)
- concomitant antimicrobial therapy
The study team makes the final eligibility decision.
Where it's taking place
- Lexington, Kentucky, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lexington, Kentucky, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.